Adults’ Adherence to Growth Hormone Replacement in Relation to Medication-Related Beliefs, Coping and Quality of Life - An Exploratory Analysis

Introduction Little is known about psychological reasons associated with adherence to growth hormone (GH) replacement therapy (GHRx) in adults. As in other chronic diseases, medication-related beliefs, coping strategies and disease impact on quality of life (QoL) might play an important role. We thus explored these psychological factors in relation to adherence in patients with GH deficiency (GHD) in order to find leverage points for the improvement of adherence. Patients and Methods Cross-sectional analysis including 107 adult GHD patients on GHRx who completed self-assessment inventories on health-related QoL (Short-Form SF-36), coping style (Freiburg questionnaire on coping with illness, FKV-LIS) and medication beliefs (Beliefs about Medicine questionnaire, BMQ). Results were correlated to general and GH-specific adherence to medication. Results In the BMQ, 92.5% of the patients (n=99) reported a strong belief in the need for their medication, which correlated significantly with general adherence (rs = 0.325). Active coping was significantly related to general (rs = 0.307) and GH-specific adherence (rs = 0.226). Better mental QoL (rs = 0.210) but worse physical QoL (rs = -0.198; all p < 0.05) were related to higher GH-specific adherence. Older age was associated with a higher degree of active coping, a higher belief in the necessity of medication and worse physical QoL. Conclusion We provide preliminary data that most GHD patients on GHRx are strongly convinced of their need for medication and that adherence to GHRx is influenced by coping strategies and QoL. Patients with impaired psychological QoL are less able to translate their convictions into good adherence, a phenomenon to be addressed in future research.

[1]  A. Wells,et al.  Metacognitive beliefs and their relationship with anxiety and depression in physical illnesses: A systematic review , 2020, PloS one.

[2]  I. Kreitschmann-Andermahr,et al.  Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients‘ perspective , 2020, Pituitary.

[3]  S. Störmann,et al.  Adherence, Attitudes and Beliefs of Growth Hormone Deficient Patients - A Questionnaire-based Cohort Study. , 2019, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[4]  S. Melmed Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults. , 2019, The New England journal of medicine.

[5]  T. Dorner,et al.  Medication Adherence and Coping Strategies in Patients with Rheumatoid Arthritis: A Cross-Sectional Study , 2019, International journal of rheumatology.

[6]  C. Camacho-Hubner,et al.  Targeted literature review of the humanistic and economic burden of adult growth hormone deficiency , 2018, Current medical research and opinion.

[7]  J. Weinman,et al.  Identifying Potentially Modifiable Factors Associated with Treatment Non-Adherence in Paediatric Growth Hormone Deficiency: A Systematic Review , 2018, Hormone Research in Paediatrics.

[8]  Arun Sivanandam,et al.  Evidence or Action , 2017 .

[9]  Jeffrey S. Gonzalez,et al.  Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. , 2016, The American psychologist.

[10]  S. Webb,et al.  Quality of life in patients with hypopituitarism , 2015, Current opinion in endocrinology, diabetes, and obesity.

[11]  C. Strasburger,et al.  Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study. , 2014, The Journal of clinical endocrinology and metabolism.

[12]  E. Erfurth Update in mortality in GH-treated patients. , 2013, The Journal of clinical endocrinology and metabolism.

[13]  M. Hernandez-Tejada,et al.  Associations between coping, diabetes knowledge, medication adherence and self-care behaviors in adults with type 2 diabetes. , 2012, General hospital psychiatry.

[14]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[15]  B. Bettencourt,et al.  Depression and medication adherence among breast cancer survivors: Bridging the gap with the theory of planned behaviour , 2011, Psychology & health.

[16]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[17]  P. Muntner,et al.  Health-related quality of life and antihypertensive medication adherence among older adults. , 2010, Age and ageing.

[18]  F. Schmidt Meta-Analysis , 2008 .

[19]  M. Dimatteo,et al.  Health Beliefs, Disease Severity, and Patient Adherence: A Meta-Analysis , 2007, Medical care.

[20]  R. Wing,et al.  Depression and Physical Illness: Depression and adherence to medical advice , 2006 .

[21]  P. Chanson,et al.  Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. , 2004, The Journal of clinical endocrinology and metabolism.

[22]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[23]  D. Feeny,et al.  Is adherence to drug treatment correlated with health-related quality of life? , 2003, Quality of Life Research.

[24]  P. Linn,et al.  Implications for Research and Practice , 2003 .

[25]  John P H Wilding,et al.  Assessment of quality of life in adults receiving long‐term growth hormone replacement compared to control subjects , 2003, Clinical endocrinology.

[26]  D. Revicki,et al.  Relationship of health‐related quality of life to treatment adherence and sustained response in chronic hepatitis C patients , 2002, Hepatology.

[27]  Brenda J. Crowe,et al.  Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? , 2002, The Journal of clinical endocrinology and metabolism.

[28]  J. Weinman,et al.  Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.

[29]  R. Horne,et al.  Patients' beliefs about treatment: the hidden determinant of treatment outcome? , 1999, Journal of psychosomatic research.

[30]  X. Badia,et al.  One‐year follow‐up of quality of life in adults with untreated growth hormone deficiency , 1998, Clinical endocrinology.

[31]  M. Bullinger [Assessment of health related quality of life with the SF-36 Health Survey]. , 1996, Die Rehabilitation.

[32]  D. Ridder,et al.  Coping, social support and chronic disease: A research agenda , 1996 .

[33]  A. Christensen,et al.  Coping with treatment-related stress: effects on patient adherence in hemodialysis. , 1995, Journal of consulting and clinical psychology.

[34]  I. Ajzen The theory of planned behavior , 1991 .

[35]  T. Revenson,et al.  Age differences in coping with chronic illness. , 1987, Psychology and aging.

[36]  Sergio Rebelo,et al.  Research Agenda , 1983, Journal of empirical research on human research ethics : JERHRE.

[37]  M. D. de Wit,et al.  Patients' perspective. , 2003, The Journal of rheumatology.

[38]  J. Weinman,et al.  The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication , 1999 .

[39]  P. Sönksen,et al.  Growth hormone deficiency and quality of life. , 1996, Hormone research.